Background illustration for clinical trials search

Pulmonary Hypertension Clinical Trials

Browse 652 pulmonary hypertension clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

for
Diabetes, Hypertension, High Cholesterol/Hyperlipidemia,
Location: Memphis TN
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT06374277

Recruiting

Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions

for
COPD, Respiratory Tract Disease,
Location: Hartford CT
Sponsor: Convexity Scientific Inc

Sex: All

Age: 18+

Code: NCT05330507

Recruiting

Thrombosis and Inflammation in Vessels Initiative (TIVI)

for
Cardiovascular Diseases, Vascular Diseases
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 5 - 70+

Code: NCT06552767

Recruiting

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging

for
Allogeneic Stem Cell Transplantation,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07613099

Phase 3, Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

for
Coronavirus Infection (COVID-19),
Location: Montreal, Durham NC, Cincinnati OH, Austin TX,
Sponsor: Duke University

Sex: All

Age: 0 - 20

Code: NCT04278404

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Comprehensive Lung Health

for
Respiratory Illness
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 21 - 70+

Code: NCT07932717

Recruiting
New

A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease

for
Atherosclerosis, Cardiovascular Disease, Hypercholesterolemia
Location: DeSoto TX
Sponsor: Verve Therapeutics, Inc.

Sex: All

Age: 18 - 70

Code: NCT07839936

Phase 2, Recruiting
New

Clinical Information System Impact on Hospitalized Patients With Chronic Disease

for
Diabete Mellitus, Kidney Disease, Heart Failure,
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07609381

Recruiting
New

Well-being Program for Caregivers of Patients With Advanced Cardiac and Pulmonary Disease

for
Caregiver, Cardiac Disease, Pulmonary Diseases
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07685912

Recruiting
New

Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

for
Severe Tricuspid Valve Regurgitation,
Location: Kingsport TN, Tulsa OK
Sponsor: Laplace Interventional, Inc

Sex: All

Age: 18 - 70+

Code: NCT07687485

Recruiting
New

Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure

for
Pregnancy-Associated Hypertension, Gestational Hypertension,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 16 - 56

Code: NCT07778966

Recruiting
New

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

for
Hypertension, Hypercortisolemia, Cushing Syndrome
Location: Jacksonville FL, Canton OH, Weslaco TX
Sponsor: RECORDATI GROUP

Sex: All

Age: 18+

Code: NCT07247162

Phase 4, Recruiting
New

Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial

for
End Stage Kidney Disease (ESKD), Hypertension (HTN),
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT07910773

Recruiting
New

Dry Weight Reduction Intervention Via Extra Ultrafiltration

for
Fluid Accumulation, Blood Pressure Management,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07637110

Recruiting
New

Renal Denervation in Patients With Atrial Fibrillation and Hypertension

for
Atrial Fibrillation (Paroxysmal), Hypertension,
Location: London
Sponsor: Pavel Antiperovitch

Sex: All

Age: 18+

Code: NCT07893821

Recruiting

Decoupling Immunotherapy Toxicity and Cancer Response

for
Tumor, Cardiovascular
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07382752

Recruiting

Age-related Macular Degeneration (AMD) and Cardiovascular Disease

for
Age-related Macular Degeneration, Coronary Artery Disease,
Location: New York NY
Sponsor: The New York Eye & Ear Infirmary

Sex: All

Age: 50+

Code: NCT04087356

Recruiting

Predictors of Respiratory Failure Following Extubation in the SICU

for
Muscle Weakness, Renal Failure, Respiratory Comorbidities
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT01967056

Recruiting

Trauma and Cardiometabolic Health in an American Indian Community

for
Psychological Stress, Cardiometabolic Conditions, Mental Health
Location: Browning MT
Sponsor: Montana State University

Sex: All

Age: 18 - 40

Code: NCT06878885

Recruiting

Extended-Release Tacrolimus Following Liver Transplantation

for
Liver Transplant; Complications, Renal Insufficiency,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05242315

Recruiting

What is pulmonary hypertension?

Pulmonary hypertension is raised blood pressure in the arteries that carry blood from the heart to the lungs. Over time the right side of the heart has to pump harder against that pressure, and it can weaken and fail. Symptoms come on slowly: breathlessness with activity, tiredness, chest pressure, dizziness or fainting, and swelling in the ankles or belly. Because these signs look like asthma, heart disease, or simply being out of shape, the diagnosis is often delayed. It is suspected on an echocardiogram and confirmed by right heart catheterization, which measures the pressure directly.

Doctors sort pulmonary hypertension into five groups by cause, and the group decides the treatment. Group 1 is pulmonary arterial hypertension, or PAH, a rare disease of the small lung arteries themselves, which can be idiopathic, inherited, or linked to conditions such as scleroderma. Group 2, the most common, comes from left sided heart disease; group 3 from lung diseases such as COPD and pulmonary fibrosis; group 4 from old blood clots in the lungs, which surgery can sometimes cure; and group 5 from other or mixed causes. Most PAH medicines are approved only for group 1, which is why most drug trials enroll people with PAH.

Types of pulmonary hypertension clinical trials

Who can participate in pulmonary hypertension clinical trials?

Groups and functional class, and why they matter for trials

How to enroll in a pulmonary hypertension clinical trial